Novartis AG (NYSE:NVS)
| 97.28 Delayed Data As of 4:00pm ET |  +0.98 / +1.02%Today’s Change | 75.68 Today|||52-Week Range 99.94 | +13.32% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 49.4B | 48.4B | 49.4B | 52.0B | |
| Cost of Goods Sold | 12.2B | 12.2B | 12.0B | 13.1B | ||
| Depreciation And Amortization | 5.2B | 5.3B | 5.2B | 5.4B | ||
| Operating Expenses | Gross Income | 32.0B | 30.9B | 32.1B | 33.6B | |
| General Expenses | 22.8B | 22.9B | 23.9B | 25.1B | ||
| Other Operating Expenses | -700.5M | -224.6M | -1.0B | -1.3B | ||
| Research And Development | 8.9B | 9.0B | 9.0B | 9.1B | ||
| Total Operating Expenses | 39.5B | 40.1B | 40.1B | 42.2B | ||
| Non-Operating Expenses | Operating Income | 9.9B | 8.3B | 9.2B | 9.8B | |
| Extraordinary Credit | 999.2K | 7.0M | 12.1M | 11.0M | ||
| Extraordinary Charge | -530.6M | -342.4M | -1.3B | -2.1B | ||
| Interest Expense On Debt | 714.4M | 736.8M | 815.0M | 998.3M | ||
| Equity In Earnings | 265.8M | 701.8M | 1.1B | 6.5B | ||
| Other Expenses | -896.3M | -198.7M | 705.4M | 406.9M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 7.9B | 7.1B | 7.9B | 7.4B | |
| Income Taxes | -1.1B | -1.1B | -1.3B | -1.2B | ||
| Minority Interest | -11.0M | -14.0M | 0.00 | -3.0M | ||
| Discontinued Operations | 10.8B | 0.00 | 0.00 | 0.00 | ||
| Net Income | 17.8B | 6.7B | 7.7B | 12.6B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 2.4B | 2.4B | 2.3B | 2.3B | |
| Shares To Calculate EPS Diluted | 2.4B | 2.4B | 2.4B | 2.3B | ||
| Earnings Per Share | EPS | $7.39 | $2.82 | $3.30 | $5.45 | |
| EPS Diluted | $7.28 | $2.80 | $3.27 | $5.39 | ||
